Capital International’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.8M | Buy |
127,607
+15,061
| +13% | +$6.71M | 2.18% | 7 |
|
2025
Q1 | $54.6M | Buy |
112,546
+1,975
| +2% | +$958K | 2.38% | 8 |
|
2024
Q4 | $44.5M | Buy |
110,571
+10,966
| +11% | +$4.42M | 1.82% | 9 |
|
2024
Q3 | $46.3M | Sell |
99,605
-866
| -0.9% | -$403K | 2% | 8 |
|
2024
Q2 | $47.1M | Buy |
100,471
+915
| +0.9% | +$429K | 2.17% | 7 |
|
2024
Q1 | $41.6M | Buy |
99,556
+14,680
| +17% | +$6.14M | 1.99% | 8 |
|
2023
Q4 | $34.5M | Buy |
84,876
+3,377
| +4% | +$1.37M | 1.77% | 7 |
|
2023
Q3 | $28.3M | Buy |
81,499
+1,259
| +2% | +$438K | 1.63% | 10 |
|
2023
Q2 | $28.2M | Buy |
80,240
+10,527
| +15% | +$3.7M | 1.58% | 8 |
|
2023
Q1 | $22M | Buy |
69,713
+4,258
| +7% | +$1.34M | 1.32% | 14 |
|
2022
Q4 | $18.9M | Sell |
65,455
-5,395
| -8% | -$1.56M | 1.3% | 17 |
|
2022
Q3 | $20.5M | Buy |
70,850
+7,483
| +12% | +$2.17M | 1.43% | 12 |
|
2022
Q2 | $17.9M | Buy |
63,367
+111
| +0.2% | +$31.3K | 1.34% | 13 |
|
2022
Q1 | $16.5M | Sell |
63,256
-20,335
| -24% | -$5.31M | 0.94% | 26 |
|
2021
Q4 | $18.4M | Buy |
83,591
+10,036
| +14% | +$2.2M | 0.93% | 24 |
|
2021
Q3 | $13.3M | Sell |
73,555
-12,473
| -14% | -$2.26M | 0.73% | 38 |
|
2021
Q2 | $17.3M | Buy |
86,028
+6,144
| +8% | +$1.24M | 0.96% | 25 |
|
2021
Q1 | $17.2M | Sell |
79,884
-1,275
| -2% | -$274K | 1.04% | 21 |
|
2020
Q4 | $19.2M | Sell |
81,159
-1,091
| -1% | -$258K | 1.12% | 21 |
|
2020
Q3 | $22.4M | Buy |
82,250
+16,221
| +25% | +$4.41M | 1.52% | 14 |
|
2020
Q2 | $19.2M | Buy |
66,029
+3,004
| +5% | +$872K | 1.79% | 13 |
|
2020
Q1 | $15M | Buy |
+63,025
| New | +$15M | 1.68% | 13 |
|
2018
Q3 | – | Sell |
-6,831
| Closed | -$1.16M | – | 167 |
|
2018
Q2 | $1.16M | Buy |
6,831
+797
| +13% | +$135K | 0.2% | 117 |
|
2018
Q1 | $983K | Buy |
+6,034
| New | +$983K | 0.18% | 126 |
|